SBI Capital Markets Limited (\Manager to the Offer\) has submitted to BSE a copy of Public Announcement for the attention of the Public Shareholders of Bliss GVS Pharma Ltd under Regulation 3(1) and Regulation 4 read with Regulation 13(1), Regulation 14 and Regulation 15(1) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 and subsequent amendments thereto.